Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2010, Article ID 174652, 9 pages
http://dx.doi.org/10.1155/2010/174652
Research Article

Racial Disparities between the Sex Steroid Milieu and the Metabolic Risk Profile

1Laboratory of Clinical and Applied Physiology, University of Miami, P.O. Box 248065, Coral Gables, FL 33124, USA
2Division of Geriatrics and Nutritional Science, Washington University School of Medicine, 660 S. Euclid Avenue, Louis street, MO 63110, USA
3Diabetes Research Institute, Miller School of Medicine, University of Miami, 1450 NW 10th Avenue, Miami, FL 33136, USA
4Department of Medicine, School of Kinesiology and Health Studies, Queen's University, Kingston, ON, Canada K7L 3N6
5Clemson University, Clemson, SC 29634, USA

Received 30 September 2009; Revised 1 February 2010; Accepted 23 April 2010

Academic Editor: Eliot Brinton

Copyright © 2010 Arlette Perry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Tchernof, M. J. Toth, and E. T. Poehlman, “Sex hormone-binding globulin levels in middle-aged premenopausal women: associations with visceral obesity and metabolic profile,” Diabetes Care, vol. 22, no. 11, pp. 1875–1881, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. S. B. Pedersen, J. D. Borglum, K. Brixen, and B. Richelsen, “Relationship between sex hormones, body composition and metabolic risk parameters in premenopausal women,” European Journal of Endocrinology, vol. 133, no. 2, pp. 200–206, 1995. View at Google Scholar · View at Scopus
  3. A. Tchernof and J.-P. Després, “Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women,” Hormone and Metabolic Research, vol. 32, no. 11-12, pp. 526–536, 2000. View at Google Scholar · View at Scopus
  4. R. J. Bell, S. L. Davison, M.-A. Papalia, D. P. McKenzie, and S. R. Davis, “Endogenous androgen levels and cardiovascular risk profile in women across the adult life span,” Menopause, vol. 14, no. 4, pp. 630–638, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Sundquist, M. A. Winkleby, and S. Pudaric, “Cardiovascular Disease Risk Factors Among Older Black, Mexican-American, and White Women and Men: an analysis of NHANES III, 1988–1994,” Journal of the American Geriatrics Society, vol. 49, no. 2, pp. 109–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. C. L. Ogden, M. D. Carroll, and K. M. Flegal, “Epidemiologic trends in overweight and obesity,” Endocrinology and Metabolism Clinics of North America, vol. 32, no. 4, pp. 741–760, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. F. L. Brancati, W. H. L. Kao, A. R. Folsom, R. L. Watson, and M. Szklo, “Incident type 2 diabetes mellitus in African American and white adults: the atherosclerosis risk in communities study,” Journal of the American Medical Association, vol. 283, no. 17, pp. 2253–2259, 2000. View at Google Scholar · View at Scopus
  8. K. Sutton-Tyrrell, R. P. Wildman, K. A. Matthews et al., “Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the study of women across the nation (SWAN),” Circulation, vol. 111, no. 10, pp. 1242–1249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. D. M. Berman, L. M. Rodrigues, B. J. Nicklas, A. S. Ryan, K. E. Dennis, and A. P. Goldberg, “Racial disparities in metabolism, central obesity, and sex hormone-binding globulin in postmenopausal women,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 1, pp. 97–103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Haffner, M. S. Katz, M. P. Stern, and J. F. Dunn, “Association of decreased sex hormone binding globulin and cardiovascular risk factors,” Arteriosclerosis, vol. 9, no. 1, pp. 136–143, 1989. View at Google Scholar · View at Scopus
  11. S. M. Haffner, “Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes,” Hormone Research, vol. 45, no. 3–5, pp. 233–237, 1996. View at Google Scholar · View at Scopus
  12. World Health Organization, “Physical Status: The Use and Interpretation of Anthropometry,” Report of a WHO Expert Committee, World Health Organization, Geneva, Switzerland, 1995. View at Google Scholar
  13. Manual of Laboratory Operations Lipid Research Clinic Program: Lipid and Lipoprotein Analysis, DHEW, Washington, DC, USA, 1974.
  14. G. R. Warnick and J. J. Albers, “A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol,” Journal of Lipid Research, vol. 19, no. 1, pp. 65–76, 1978. View at Google Scholar · View at Scopus
  15. L. I. Gidez, G. J. Miller, and M. Burstein, “Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure,” Journal of Lipid Research, vol. 23, no. 8, pp. 1206–1223, 1982. View at Google Scholar · View at Scopus
  16. M. W. McGowan, J. D. Artiss, D. R. Strandbergh, and B. Zak, “A peroxidase-coupled method for the colorimetric determination of serum triglycerides,” Clinical Chemistry, vol. 29, no. 3, pp. 538–542, 1983. View at Google Scholar · View at Scopus
  17. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  18. R. M. Krauss and D. J. Burke, “Identification of multiple subclasses of plasma low density lipoproteins in normal humans,” Journal of Lipid Research, vol. 23, no. 1, pp. 97–104, 1982. View at Google Scholar · View at Scopus
  19. S. M. Haffner, H. Miettinen, and M. P. Stern, “The homeostasis model in the San Antonio Heart Study,” Diabetes Care, vol. 20, no. 7, pp. 1087–1092, 1997. View at Google Scholar · View at Scopus
  20. L. F. Blight, S. J. Judd, and G. H. White, “Relative diagnostic value of serum non-SHBG-bound testosterone, free androgen index and free testosterone in the assessment of mild to moderate hirsutism,” Annals of Clinical Biochemistry, vol. 26, no. 4, pp. 311–316, 1989. View at Google Scholar · View at Scopus
  21. A. Vermeulen, L. Verdonck, and J. M. Kaufman, “A critical evaluation of simple methods for the estimation of free testosterone in serum,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 10, pp. 3666–3672, 1999. View at Google Scholar · View at Scopus
  22. R. S. Paffenbarger Jr., S. N. Blair, I.-M. Lee, and R. T. Hyde, “Measurement of physical activity to assess health effects in free-living populations,” Medicine and Science in Sports and Exercise, vol. 25, no. 1, pp. 60–70, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Rosmond, L. Lapidus, and P. Björntorp, “The influence of occupational and social factors on obesity and body fat distribution in middle-aged men,” International Journal of Obesity, vol. 20, no. 7, pp. 599–607, 1996. View at Google Scholar · View at Scopus
  24. P. J. Brantley, L. S. Dietz, G. T. McKnight, G. N. Jones, and R. Tulley, “Convergence between the daily stress inventory and endocrine measures of stress,” Journal of Consulting and Clinical Psychology, vol. 56, no. 4, pp. 549–551, 1988. View at Google Scholar · View at Scopus
  25. SPSS for Windows, release 10.1, SPSS, Inc, Chicago, Ill, USA, 2000.
  26. J. M. Conway, S. Z. Yanovski, N. A. Avila, and V. S. Hubbard, “Visceral adipose tissue differences in black and white women,” American Journal of Clinical Nutrition, vol. 61, no. 4, pp. 765–771, 1995. View at Google Scholar · View at Scopus
  27. J. B. Albu, L. Murphy, D. H. Frager, J. A. Johnson, and F. X. Pi-Sunyer, “Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women,” Diabetes, vol. 46, no. 3, pp. 456–462, 1997. View at Google Scholar · View at Scopus
  28. H. J. Dowling and F. X. Pi-Sunyer, “Race-dependent health risks of upper body obesity,” Diabetes, vol. 42, no. 4, pp. 537–543, 1993. View at Google Scholar · View at Scopus
  29. D. Goodman-Gruen and E. Barrett-Connor, “Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women,” International Journal of Obesity, vol. 19, no. 5, pp. 293–298, 1995. View at Google Scholar · View at Scopus
  30. P. M. Sarrel, “Cardiovascular aspects of androgens in women,” Seminars in Reproductive Endocrinology, vol. 16, no. 2, pp. 121–128, 1998. View at Google Scholar · View at Scopus
  31. T. Kienitz and M. Quinkler, “Testosterone and blood pressure regulation,” Kidney and Blood Pressure Research, vol. 31, no. 2, pp. 71–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Livingstone and M. Collison, “Sex steroids and insulin resistance,” Clinical Science, vol. 102, no. 2, pp. 151–166, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Stampfer, F. M. Sacks, S. Salvini, W. C. Willett, and C. H. Hennekens, “A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction,” New England Journal of Medicine, vol. 325, no. 6, pp. 373–381, 1991. View at Google Scholar · View at Scopus
  34. K. Sherif, H. Kushner, and B. E. Falkner, “Sex hormone-binding globulin and insulin resistance in African-American women,” Metabolism, vol. 47, no. 1, pp. 70–74, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. E. S. Ford, W. H. Giles, and W. H. Dietz, “Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey,” Journal of the American Medical Association, vol. 287, no. 3, pp. 356–359, 2002. View at Google Scholar · View at Scopus
  36. D. Lloyd-Jones, R. J. Adams, T. M. Brown et al., “Heart disease and stroke statistics—2010 update: a report from the American Heart Association,” Circulation, vol. 121, no. 7, pp. 948–954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. S. Ryan, B. J. Nicklas, and D. M. Berman, “Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women,” Obesity Research, vol. 10, no. 5, pp. 336–344, 2002. View at Google Scholar · View at Scopus
  38. J. C. Lovejoy, J. A. de la Bretonne, M. Klemperer, and R. Tulley, “Abdominal fat distribution and metabolic risk factors: effects of race,” Metabolism, vol. 45, no. 9, pp. 1119–1124, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Haffner, “Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation,” International Journal of Obesity, vol. 24, no. 2, pp. S56–S58, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. R. L. Barbieri and K. J. Ryan, “Hyperandrogenism, Insulin Resistance, and Acanthosis Nigricans Syndrome. A Common Endocrinopathy with Distinct Pathophysiologic Features,” American Journal of Obstetrics and Gynecology, vol. 147, no. 1, pp. 90–101, 1983. View at Google Scholar · View at Scopus
  41. S. R. Plymate, L. A. Matej, R. E. Jones, and K. E. Friedl, “Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin,” Journal of Clinical Endocrinology and Metabolism, vol. 67, no. 3, pp. 460–464, 1988. View at Google Scholar · View at Scopus